These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1701232)

  • 1. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.
    Santoro M; Rosati R; Grieco M; Berlingieri MT; D'Amato GL; de Franciscis V; Fusco A
    Oncogene; 1990 Oct; 5(10):1595-8. PubMed ID: 1701232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.
    Miya A; Yamamoto M; Morimoto H; Tanaka N; Shin E; Karakawa K; Toyoshima K; Ishizaka Y; Mori T; Takai S
    Henry Ford Hosp Med J; 1992; 40(3-4):215-9. PubMed ID: 1362408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method.
    Ishizaka Y; Kobayashi S; Ushijima T; Hirohashi S; Sugimura T; Nagao M
    Oncogene; 1991 Sep; 6(9):1667-72. PubMed ID: 1717926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
    Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N
    J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients.
    Itoh F; Ishizaka Y; Tahira T; Yamamoto M; Miya A; Imai K; Yachi A; Takai S; Sugimura T; Nagao M
    Oncogene; 1992 Jun; 7(6):1201-6. PubMed ID: 1350670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RET proto-oncogene mutations and rearrangements in endocrine diseases.
    Lloyd RV
    Am J Pathol; 1995 Dec; 147(6):1539-44. PubMed ID: 7495277
    [No Abstract]   [Full Text] [Related]  

  • 8. The RET proto-oncogene in sporadic pheochromocytomas.
    Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
    Intern Med; 1996 Jun; 35(6):449-52. PubMed ID: 8835594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
    Eng C; Foster KA; Healey CS; Houghton C; Gayther SA; Mulligan LM; Ponder BA
    Br J Cancer; 1996 Aug; 74(3):339-41. PubMed ID: 8695346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.
    Fabien N; Paulin C; Santoro M; Berger N; Grieco M; Galvain D; Barbier Y; Dubois PM; Fusco A
    Br J Cancer; 1992 Dec; 66(6):1094-8. PubMed ID: 1457350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
    Grieco M; Santoro M; Berlingieri MT; Melillo RM; Donghi R; Bongarzone I; Pierotti MA; Della Porta G; Fusco A; Vecchio G
    Cell; 1990 Feb; 60(4):557-63. PubMed ID: 2406025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas.
    Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M
    Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia.
    Zou M; Shi Y; Farid NR
    Cancer; 1994 Jan; 73(1):176-80. PubMed ID: 8275421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.
    Eng C; Smith DP; Mulligan LM; Nagai MA; Healey CS; Ponder MA; Gardner E; Scheumann GF; Jackson CE; Tunnacliffe A
    Hum Mol Genet; 1994 Feb; 3(2):237-41. PubMed ID: 7911697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin.
    Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
    J Mol Med (Berl); 1996 Oct; 74(10):617-21. PubMed ID: 8912182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
    Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
    Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
    Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
    Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
    Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
    Mulligan LM; Kwok JB; Healey CS; Elsdon MJ; Eng C; Gardner E; Love DR; Mole SE; Moore JK; Papi L
    Nature; 1993 Jun; 363(6428):458-60. PubMed ID: 8099202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
    Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
    Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.